BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7269869)

  • 1. [Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)].
    Opri F; Kirchner H
    Zentralbl Gynakol; 1981; 103(10):564-8. PubMed ID: 7269869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
    Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of CEA in benign breast disease (author's transl)].
    Opri F; Kirchner H; Mayfeld K
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
    Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
    Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
    Agbedana EO; Ebesunun MO
    Afr J Med Med Sci; 1998; 27(1-2):65-9. PubMed ID: 10456133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcino-embryonic antigen and beta 2 microglobulin in malignant bone diseases. 61 cases (author's transl)].
    Trèves R; Clément A; Desproges-Gotteron R; Olivier JP; Beck C
    Nouv Presse Med; 1982 Jan; 11(1):21-4. PubMed ID: 6173840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acid phosphatase activity in breast dysplasias and in carcinomas of the breast].
    Panazzolo A; Verna L; Cacciari P; Massobrio M; Frea F
    Arch Sci Med (Torino); 1976; 133(1):12-36. PubMed ID: 184755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of hydrolytic enzyme activities in breast cancer].
    Vierbuchen M; Würz H; Fischer R
    Verh Dtsch Ges Pathol; 1985; 69():131-4. PubMed ID: 4096102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of carcino-embryonic antigen and beta2-microglobulin. Methodological study and clinical interpretation (author's transl)].
    Depierre A; Kadouche J; Chamagne AM; Najean Y
    Pathol Biol (Paris); 1978 Sep; 26(6):341-2. PubMed ID: 83578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA positivity in tissue and sera of patients with benign breast lesions.
    Wittekind C; Von Kleist S; Sandritter W
    Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
    Wurster K; Heberling D; Rapp W
    Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of benign tumors and mammary dysplasias in cancerogenesis as related to lysosomal alpha-arylsulfatase and beta-glucoronidase enzyme activity].
    De Sanso G; Bracco G; Tanferna M; Graffino W; Panazzolo A
    Minerva Ginecol; 1981; 33(2-3):185-96. PubMed ID: 6265834
    [No Abstract]   [Full Text] [Related]  

  • 16. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
    Anticancer Res; 1998; 18(2B):1243-9. PubMed ID: 9615795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
    Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor antigens in the diagnosis of gastroenterological diseases (author's transl)].
    Lehmann FG
    Leber Magen Darm; 1975 Aug; 5(4):144-58. PubMed ID: 57561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.
    Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J
    Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.